Autologous stem cell transplantation in the treatment of multiple myeloma single center experience
Background/Aim. In comparison to standard therapy autologous stem cell transplant (ASCT) with high doses melphalane has improved treatment of multiple myeloma (MM) patients. The aim of this study was to evaluate the results of treatment of MM patients in our center with ASCT conditioning with me...
Main Authors: | Marjanović Slobodan, Stamatović Dragana, Tukić Ljiljana, Tarabar Olivera, Elez Marija, Mađaru Lavinika, Balint Bela, Tatomirović Željka, Kuljić-Kapulica Nada, Anđelković Nebojša |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2011-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501105387M.pdf |
Similar Items
-
Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies
by: Stamatović Dragana, et al.
Published: (2011-01-01) -
Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy
by: Stamatović Dragana, et al.
Published: (2012-01-01) -
Monitoring of cytomegalovirus infection after allogeneic stem cell transplantation
by: Kuljić-Kapulica Nada, et al.
Published: (2010-01-01) -
AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01) -
UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)